These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24955483)

  • 1. Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.
    Bayramoglu A; Gunes HV; Metintas M; Degirmenci I; Guler HI; Ustuner C; Musmul A
    Genet Test Mol Biomarkers; 2014 Aug; 18(8):587-90. PubMed ID: 24955483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
    Cosan D; Kurt E; Kurt H; Degirmenci I; Kuçukarabaci B; Metintas M; Kucuk MU; Gunes HV; Colak E
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
    Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
    Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.
    Bayram B; Sayin E; Erkasap N; Onlü H; Ozkurt M; Sahin F; Türkoğlu Z
    Rheumatol Int; 2012 Jan; 32(1):259-62. PubMed ID: 21240498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population.
    Gunes HV; Cosan DT; Ata N; Birdane A; Ustuner MC; Dikmen M; Bayram B; Degirmenci I
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):303-5. PubMed ID: 20392162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke.
    Kucukarabaci B; Gunes HV; Ozdemir G; Cosan D; Ozbabalik D; Dikmen M; Degirmenci I
    Genet Test; 2008 Sep; 12(3):443-51. PubMed ID: 18662099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
    Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the -844 G>A, HindIII C>G, and 4G/5G
    Valdés-Alvarado E; Huerta M; Trujillo X; Valle Y; Padilla Gutiérrez JR; Mireles-Ramírez MA; Macías-Islas MA; Luz Margarita BR; Muñoz-Valle JF
    Dis Markers; 2019; 2019():9626289. PubMed ID: 31687051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
    Ozbek OY; Ataç FB; Ogus E; Ozbek N
    Allergy Asthma Proc; 2009; 30(1):41-6. PubMed ID: 19063817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAI-1 mRNA expression and plasma level in rheumatoid arthritis: relationship with 4G/5G PAI-1 polymorphism.
    Muñoz-Valle JF; Ruiz-Quezada SL; Oregón-Romero E; Navarro-Hernández RE; Castañeda-Saucedo E; De la Cruz-Mosso U; Illades-Aguiar B; Leyva-Vázquez MA; Castro-Alarcón N; Parra-Rojas I
    Rheumatol Int; 2012 Dec; 32(12):3951-6. PubMed ID: 22200807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D; Yurdakök M; Okur H; Gürgey A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):352-7. PubMed ID: 20460339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population.
    Shammaa DM; Sabbagh AS; Taher AT; Zaatari GS; Mahfouz RA
    Mol Biol Rep; 2008 Sep; 35(3):453-7. PubMed ID: 17578681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
    Błasiak J; Smolarz B
    Acta Biochim Pol; 2000; 47(1):191-9. PubMed ID: 10961693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of Plasminogen Activator Inhibitor 1 4G/5G Gene Polymorphism and Nontraumatic Lunatum Avascular Necrosis.
    Gönen M; Yörükoğlu AÇ; Aydemir AN; Gönen GA; Tepeli E; Demirkan AF
    J Hand Surg Am; 2020 May; 45(5):450.e1-450.e4. PubMed ID: 31806394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
    Iwai N; Shimoike H; Nakamura Y; Tamaki S; Kinoshita M
    Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.
    Lampalo M; Jukic I; Bingulac-Popovic J; Marunica I; Petlevski R; Pavlisa G; Popovic-Grle S
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2613-2619. PubMed ID: 28258374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.